Compare RBLX & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RBLX | WST |
|---|---|---|
| Founded | 2006 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9B | 23.9B |
| IPO Year | 2020 | 2004 |
| Metric | RBLX | WST |
|---|---|---|
| Price | $43.01 | $363.90 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 35 | 17 |
| Target Price | $48.97 | ★ $407.56 |
| AVG Volume (30 Days) | ★ 9.6M | 375.2K |
| Earning Date | 10-29-2026 | 10-22-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | N/A | ★ 1.49 |
| EPS | N/A | ★ 4.07 |
| Revenue | $2,225,052,000.00 | ★ $2,886,900,000.00 |
| Revenue This Year | $41.07 | $9.75 |
| Revenue Next Year | $12.43 | $6.32 |
| P/E Ratio | ★ N/A | $91.59 |
| Revenue Growth | ★ 15.94 | 1.95 |
| 52 Week Low | $33.88 | $223.83 |
| 52 Week High | $141.95 | $386.00 |
| Indicator | RBLX | WST |
|---|---|---|
| Relative Strength Index (RSI) | 44.67 | 58.04 |
| Support Level | $40.42 | $346.45 |
| Resistance Level | $52.49 | $384.35 |
| Average True Range (ATR) | 2.28 | 8.01 |
| MACD | -0.86 | 0.78 |
| Stochastic Oscillator | 17.47 | 62.89 |
Roblox operates a free-to-play online video game platform with nearly 125 million daily active users. This platform has spawned a virtual universe and a Roblox economy based on the Robux currency. The platform houses millions of games from a wide range of creators—spanning from young gamers themselves to professional development studios. Roblox offers creators the tools, publishing abilities, and platform for their games, enabling anyone to create a game. Creators earn money when gamers make optional in-game purchases within their games and by offering space for real-world advertising, and Roblox earns revenue primarily by taking a cut of these earnings.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.